Citation Impact
Citing Papers
Exosomes for drug delivery — a novel application for the mesenchymal stem cell
2012
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
2011 Standout
Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery
2012
Multifunctional Lipid/Quantum Dot Hybrid Nanocontainers for Controlled Targeting of Live Cells
2006 StandoutNobel
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome
2006
Hidradenitis suppurativa: A comprehensive review
2009 Standout
Nanoparticles in Medicine: Therapeutic Applications and Developments
2007 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata
2008
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
2009 Standout
A review of stimuli-responsive nanocarriers for drug and gene delivery
2008 Standout
The human keratins: biology and pathology
2008 Standout
U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease
2008
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
2010
Efficacy and safety of liposomal anthracyclines in Phase I/II clinical trials
2004
Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group
2005
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
Polymer conjugates as anticancer nanomedicines
2006 Standout
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Characterization of a Novel Human Type II Epithelial Keratin K1b, Specifically Expressed in Eccrine Sweat Glands
2005
The golden age: gold nanoparticles for biomedicine
2011 Standout
Current management strategies for cutaneous T-cell lymphoma
2004
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
Extracorporeal photochemoimmunotherapy in cutaneous T-cell lymphoma
2003
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
2017
Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
2011 StandoutNobel
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
2010 Standout
Tumor delivery of macromolecular drugs based on the EPR effect
2010 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
The skin: an indispensable barrier
2008 Standout
Clinical and Pathological Features of Pachyonychia Congenita
2005
Targeted pharmaceutical nanocarriers for cancer therapy and imaging
2007
Epithelial markers and differentiation in adnexal neoplasms of the skin: an immunohistochemical study including individual cytokeratins
1995
Development of ligand-targeted liposomes for cancer therapy
2004
Mesoporous Materials for Drug Delivery
2007 Standout
Liposomes as nanomedical devices
2015 Standout
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
Knocking down barriers: advances in siRNA delivery
2009 Standout
Review of extracorporeal photopheresis in early‐stage (IA, IB, and IIA) cutaneous T‐cell lymphoma
2007
Extracellular vesicles: biology and emerging therapeutic opportunities
2013 Standout
Phenol Oxidase (EC 1.14.18.1) A Marker Enzyme for Defense Cells
1988
Delivering nanomedicine to solid tumors
2010 Standout
Mycosis fungoides and the Sézary syndrome
2004
Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example
2009
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis
2019 Standout
Clinical Pharmacology of Liposomal Anthracyclines: Focus on Pegylated Liposomal Doxorubicin
2008
Ultrastructural Localization of Calcium in Psoriatic and Normal Human Epidermis
1991
Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers
2009 Standout
Romidepsin: A Histone Deacetylase Inhibitor for Refractory Cutaneous T-Cell Lymphoma
2012
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
2011 StandoutNobel
Electrosprayed nanoparticles and electrospun nanofibers based on natural materials: applications in tissue regeneration, drug delivery and pharmaceuticals
2014 Standout
Plant Products as Antimicrobial Agents
1999 Standout
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Natural product and natural product derived drugs in clinical trials
2014 Standout
Synthesis of random copolymer based pH-responsive nanoparticles as drug carriers for cancer therapeutics
2013 StandoutNobel
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
2007 Standout
CutaneousT ‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
2015
Exosomes as drug delivery vehicles for Parkinson's disease therapy
2015 Standout
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
A retrospective comparative outcome analysis following systemic therapy in M ycosis fungoides and S ezary syndrome
2016
How I treat mycosis fungoides and Sézary syndrome
2016
Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?
2016
The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society
2017
Works of B Knopf being referenced
[In-vitro-investigation of immuno lymphocytolysis by influence of streptolysin O (author's transl)].
1977
Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: A prospective controlled trial
2001
Immunolocalization of cytokeratins in human eccrine sweat glands
1990
Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T‐cell lymphoma
2003
Treatment of Cutaneous T Cell Lymphoma Stage II with Interferon‐α‐2a and Extracorporeal Photochemotherapy
2001
Topical interferon-alpha in psoriasis increases epidermal calmodulin activity
1990
Increase of epidermal calmodulin precedes the formation of a psoriatic lesion
1989
[Immunohistologic studies of the distribution of proliferative compartments in the appendages of adult human skin].
1990
Pachyonychia congenita. Immunohistologic findings.
1991